All In Biotech

Drug Trial Radar · NCT07284849

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 700 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

700

Planned (sponsor's estimate)

Start

Mar 5, 2026

Primary completion

Dec 29, 2028

Study completion Sep 28, 2029

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Dec 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of standard-of-care chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite stable colorectal cancer.

Conditions

  • CRC (Colorectal Cancer)

Interventions

  • INCA33890Drug

    INCA33890 will be administered at protocol defined dose.

  • PlaceboDrug

    Placebo will be administered at protocol defined dose.

  • BevacizumabDrug

    Bevacizumab will be administered at protocol defined dose.

  • FOLFOXDrug

    FOLFOX will be administered at protocol defined dose.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-Free Survival (PFS)Time frame: Up to 3 years

Locations

297 sites in 22 countries. Site status is shown where the registry gives one.

  • Mitchell Cancer Institute

    Mobile, Alabama · Not yet recruiting

  • The University of Arizona Cancer Center

    Tucson, Arizona · Recruiting

  • Roche Tissue Diagnostics, Companion Diagnostics

    Tucson, Arizona · Recruiting

  • Memorial Care Orange Coast Medical Center

    Fountain Valley, California · Recruiting

  • Providence Medical Foundation

    Fullerton, California · Recruiting

  • Cancer & Blood Research Center

    Los Alamitos, California · Recruiting

  • University of California Los Angeles Health

    Los Angeles, California · Not yet recruiting

  • Oncura Health

    Sacramento, California · Recruiting

  • Sarah Cannon Research Institute Scri Oncology Partners

    Aurora, Colorado · Recruiting

  • Hartford Hospital

    Hartford, Connecticut · Not yet recruiting

  • George Washington University

    Washington D.C., District of Columbia · Not yet recruiting

  • Florida Oncology & Hematology

    Fort Myers, Florida · Recruiting

  • University of Florida Health

    Gainesville, Florida · Recruiting

  • Sylvester Comprehensive Cancer Center

    Miami, Florida · Recruiting

  • Advent Health

    Orlando, Florida · Not yet recruiting

  • Orlando Health Cancer Institute Downtown Orlando

    Orlando, Florida · Not yet recruiting

  • Ascension Sacred Heart Pensacola

    Pensacola, Florida · Recruiting

  • Tampa General Hospital-Cancer Institute

    Tampa, Florida · Not yet recruiting

  • Total Health Center

    Decatur, Georgia · Not yet recruiting

  • Piedmont Cancer Institute

    Locust Grove, Georgia · Recruiting

  • University of Hawaii Cancer Center

    Honolulu, Hawaii · Not yet recruiting

  • St Lukes Mountain States Tumor Institute Msti Boise

    Boise, Idaho · Not yet recruiting

  • Sih Cancer Institute

    Carterville, Illinois · Recruiting

  • University of Illinois Cancer Center

    Chicago, Illinois · Recruiting

  • Alexian Brothers Medical Center

    Elk Grove Village, Illinois · Not yet recruiting

  • Endeavor Health

    Evanston, Illinois · Recruiting

  • Springfield Clinic

    Springfield, Illinois · Recruiting

  • Community Health Network, Inc.

    Indianapolis, Indiana · Recruiting

  • Hematology Oncology of Indiana

    Indianapolis, Indiana · Recruiting

  • University of Iowa Hospital and Clinics

    Iowa City, Iowa · Not yet recruiting

  • Saint Agnes Hospital

    Baltimore, Maryland · Recruiting

  • Cancer Center For Blood Disorders A Division of American Oncology Partners P.A

    Bethesda, Maryland · Recruiting

  • Sarah Cannon Research Institute Scri Oncology Partners

    Brandywine, Maryland · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Not yet recruiting

  • Trinity Health St Joseph Mercy Ann Arbor

    Ann Arbor, Michigan · Recruiting

  • Henry Ford Hospital

    Detroit, Michigan · Not yet recruiting

  • Missouri Cancer Associates

    Columbia, Missouri · Recruiting

  • Saint Luke'S Hospital of Kansas City

    Kansas City, Missouri · Recruiting

  • Midamerica Cancer Care

    Kansas City, Missouri · Recruiting

  • Oncology Hematology Associates

    Springfield, Missouri · Recruiting

Showing 40 of 297 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.